Evidence map›Paper›PMID 42274784›Full record

Observational studyJournal of neurology2026

Acute non-alcoholic caffeinated beverage consumption as a trigger for cryptogenic ischemic stroke in the young: findings from the SECRETO study.

Phillip Ferdinand, Ram Bajpai, Bettina von Sarnowski, Pauli Ylikotila, Marialuisa Zedde, Tomi Sarkanen, Kristina Ryliskiene, Nicolas Martinez-Majander, Lauri Tulkki, Radim Licenik and 19 more

Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01934725 (Searching for Explanations for Cryptogenic Stroke in the Young), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01934725 active not recruitingnot on this map

Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome (SECRETO)

TypeobservationalSponsorSECRETO Study ConsortiumRan2013 to 2031Enrolled1,200ConditionsBrain Infarction, Ischemic Stroke, Thrombosis, Foramen Ovale, Patent
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Phillip FerdinandNeurosciences, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK. phillip.ferdinand@uhnm.nhs.uk.ORCID http://orcid.org/0000-0002-8715-2917
Ram BajpaiSchool of Medicine, Keele University, Staffordshire, UK.
Bettina von SarnowskiDepartment of Neurology, University Medicine Greifswald, Greifswald, Germany.
Pauli YlikotilaDepartment of Neurology, Turku University Hospital and University of Turku, Turku, Finland.
Marialuisa ZeddeNeurology Unit, Stroke Unit, Azienda Unità Sanitaria Locale-IRCCS Reggio Emilia, Reggio Emilia, Italy.
Tomi SarkanenDepartment of Neurology, Tampere University Hospital, Tampere, Finland.
Kristina RyliskieneFaculty of Medicine, Center of Neurology, Vilnius University, Vilnius, Lithuania.
Nicolas Martinez-MajanderDepartment of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Lauri TulkkiDepartment of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Radim LicenikNorth West Anglia NHS Foundation Trust Acute Stroke Centre, Peterborough, UK.
Janika KõrvDepartment of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.
Liisa KõrvDepartment of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.
Alessandro PezziniDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Ana Catarina FonsecaHospital Santa Maria, CHLN, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Patricia Martinez-SanchezDepartment of Neurology, Torrecardenas University Hospital, University of Almería, Almería, Spain.
Laura Amaya-PascasioDepartment of Neurology, Torrecardenas University Hospital, University of Almería, Almería, Spain.
Nilufer YesilotIstanbul Faculty of Medicine, Department of Neurology, Istanbul University, Istanbul, Turkey.
Ulrike Waje-AndreassenDepartment of Neurology, Haukeland University Hospital, Bergen, Norway.
Annette FrommDepartment of Neurology, Haukeland University Hospital, Bergen, Norway.
Juha HuhtakangasDepartment of Neurology, Oulu University Hospital and University of Oulu, Oulu, Finland.
Ulla JunttolaDepartment of Neurology, Oulu University Hospital and University of Oulu, Oulu, Finland.
Pekka JäkäläNeurocenter Neurology, Kuopio University Hospital, Kuopio, Finland.
Anne-Mari KantanenNeurocenter Neurology, Kuopio University Hospital, Kuopio, Finland.
Petra RedforsDepartment of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Juha SinisaloDepartment of Cardiology, Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Eva GerdtsCenter for Research On Cardiac Disease in Women, Department of Clinical Science, University of Bergen, Bergen, Norway.
Turgut TatlisumakDepartment of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Christine RoffeNeurosciences, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
Jukka PutaalaDepartment of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Funding

Academy of Finland 286246Academy of Finland 318075Academy of Finland 322656Helsinki and Uusimaa Hospital District research fund TYH2014407Helsinki and Uusimaa Hospital District research fund TYH2018318Sahlgrenska University Hospital ALFGBG-726821
6 · The paper itself

Abstract

introductionCryptogenic ischemic stroke (CIS) is responsible for the increase in young ischemic strokes. We investigated non-alcoholic caffeinated beverages as a trigger for young CIS, in a large multi-center, case-control study.

methodsIn Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome (SECRETO; NCT01934725), patients 18-49 years old suffering first ever CIS were recruited within 2 weeks of symptom onset. A structured questionnaire obtained information on coffee, tea, and cola consumption in the last 12 months, usual daily consumption, consumption 24 h preceding stroke and timing of the last consumption prior to stroke. Case-crossover analysis was performed using the Mantel-Haenszel method.

results598 CIS patients (54.7% male, mean age 39.4 [standard deviation 8.2]) were analyzed. Case-crossover analysis found association with coffee consumption in the 1-h (relative risk [RR] 1.73, 95% confidence interval [CI] 1.06-2.83) and 2-h (RR 2.15, 95%CI 1.40-3.29) hazard periods, tea consumption in the 1-h (RR 3.93, 95%CI 1.04-14.95) and 2- hour (RR 4.89, 95%CI 1.92-12.50) hazard periods and cola consumption (RR 3.70, 95%CI 1.18-11.62) in the 2-h hazard period. Sub-group analysis in the 2-h hazard period found coffee consumption was associated in both sexes and age groups, high-risk patent foramen ovale (PFO), mild/moderate stress and both low-/high-risk factor burden. Tea consumption was associated in both sexes and age groups and those without PFO.

conclusionCoffee, tea, and cola consumption as potential trigger factors were associated with young CIS patients within the 2-h hazard period, with coffee and tea maintaining association in several sub-groups.

Indexed as

BeveragesCaffeineCarbonated BeveragesCoffeeColaIschemic StrokeTeaAdolescentAdultCase-Control StudiesCross-Over StudiesFemaleHumansMaleMiddle AgedYoung AdultCaffeineCoffeeTeaCase-crossover analysisCryptogenic ischemic strokeTriggers of ischemic strokeYoung ischemic stroke

Identifiers

PMID42274784
PMCPMC13260097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.